期刊文献+

L-苯丙氨醇质量控制研究

Quality Control of L-Phenylalaninol
下载PDF
导出
摘要 建立L-苯丙氨醇质量内控方法.采用反相高效液相色谱法,用Phenomenex Gemini C18(4.6×250 mm,5μm)柱,以乙腈-0.02 mol/L磷酸二氢钾溶液(含0.1%三乙胺)(8∶92)为流动相,在206 nm测定.L-苯丙氨醇在0.01~0.23μg/μL范围内线性关系良好(r=0.9999);回收率为100.30%(RSD=1.60%).采用比旋光度法控制其光学纯度. To develop the quality standard for L-phenylalaninol. The content of L-phenylalaninol was determined by reversed-phase high performance liquid chromatography(RP-HPLC)with the column of Phenomenex Gemini Ci8(4.6-250mm, 5 p.m) and the mobile phase of acetonitrile:20 mM potassium dihydrogen phosphateat containing 0.1% triethylamine(8 : 92) at 206 nm. The linear range of L-phenylalaninol was 0.01-0.23μg/μL (r = 0.9999) and the average recovery of L-phenylalaninol was 100.30 %(RSD = 1.60). The enantiospecific analysis of L-phenylalaninol was monitored by the power rotation.
出处 《广东化工》 CAS 2014年第8期11-12,共2页 Guangdong Chemical Industry
基金 "十二五"国家重大新药创制科技重大专项(2011ZX09102-009-002) 贵州省中药现代化科技产业研究开发专项(黔科合中药字[2012]5054) 贵州省创新人才基地(黔人领发[2011]1号)
关键词 L-苯丙氨醇 高效液相色谱法 质量控制 L-phenylalaninol: RP-HPLC quality control
  • 相关文献

参考文献7

二级参考文献33

  • 1赵玲,郭继芬,张爱军,赵毅民.利用LC-MS/MS法快速鉴定盐酸头孢吡肟中的同分异构体杂质[J].药学学报,2005,40(4):361-364. 被引量:9
  • 2包俊 冉懋雄 陆科闵 等.贵州苗族医药研究与开发[M].贵阳:贵州科技出版社,1999.200.
  • 3贵州省卫生厅.“贵州省药品标准”1994年版,贵阳,1994.25
  • 4Junichi Kitajima, Nobuyuki Suzuki,Toru ishikawa, et al. New hemiterpenoid pentol and monoterpenoid glycoside of Torillis japonica fruit, and consideration of the origin of apiose. Chemical and Pharmaceutical Bullin, 1998,46(10):1583~1586
  • 5Hirozi Suzuki, Tsutomu Ikeda, Takashi Matsumoto, et al.Polyphenol components in culured cells of amaeha(Hydrangea macrophylla Seringe var. Thunbergii Makino). Agric Biol Chem, 1978,42(6):1133~1137
  • 6Pang R,Tao JY,Zhang SL,ef al. In vitro antiviral activity of lute-in against hepatitis B virus [ J]. Phyiother Res,2010,24 (11):1627-1 630.
  • 7Lin KW,Kirchner JT. Information from your family doctor:hepati-tis B infection [ J ]. Am Farn Physician ,2004,69 (1) :86.
  • 8Park N,Song I,Chung Y. Chronic hepatitis B in hepatocarcino-genesis[ J] ? Postgrad Med 7,2006,82(970) :507 -515.
  • 9Karayiannis P. Current therapies for chronic hepatitis B virus in-fection[ J]. Expert Rev Anti Infect 77ier,2004,2(5) :745 -760.
  • 10Fattovich G,Brollo L,Giustina G,et al. Natural-history and prog-nostic factors for chronic hepatitis type B[ J]. Gul,1991,32(3);294 -298.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部